11:44 AM EST - ProMIS Neurosciences, Inc. : Has acquired an exclusive, worldwide license to Collective Coordinates, a method to predict novel therapeutic targets in Alzheimer's and other neurodegenerative diseases. A provisional patent application for the Collective Coordinates method was submitted to the United States Patent Office on Monday, Nov. 9. ProMIS Neurosciences, Inc.
shares T.PMN are trading up $0.01 at $0.07.
